Have you or a loved one had the Cartiva toe implant and faced painful failure, swelling, or a second surgery? Lawsuits against Stryker are exploding—over 200 cases filed in 2025 alone, plus the first bellwether trial delayed this year. Discover the hidden failure risks, FDA’s full recall after 144+ adverse reports, and how Direct2Attorney connects you to top lawyers for free. No win, no fee—claim your payout before the statute runs out!
What Is the Cartiva Implant Lawsuit?
The Cartiva implant is like a soft, jelly-like “fake cushion” doctors put in your big toe to stop arthritis pain from bones rubbing together. Okayed by the FDA in 2016, the company (Cartiva, Inc., then bought by Wright Medical and Stryker) sold it as an easy swap for worn-out toe cartilage. They promised it’d last 10-15 years, keep your toe bendy, cut pain fast, and let you walk or run without the hassle of stiff fusion surgery – great for the 2 million+ folks with big toe arthritis who hate limping or missing fun stuff.
But here’s the bad news: It breaks down way too often. Real studies show 50-79% fail in 1-2 years (not the company’s fake-low 13.5%). The jelly shrinks, cracks, slips, or sinks into bone, causing killer pain, swelling, infections, bone holes (osteolysis), cysts, and lumpy growths (granulomas). Most people (up to 2/3) need a tough follow-up surgery to pull it out and glue the toe bones forever – ouch, more pain, no bend, lost work days, and trouble with shoes or stairs. Over 200 easy-to-read lawsuits by late 2025 blame Stryker for junk design, weak tests on tiny groups, lying to the FDA with short studies, and hiding 144+ bad reports to cash in. If your toe implant flopped, you could get money for doctor bills, missed pay, and daily misery – chat with Direc2Attorney now for a free check, no fees till you win!
At Direct2Attorney, we believe in your right to justice.
Our legal specialists will review your case thoroughly to identify your options.
We will assess your eligibility and assist you in filing your case, ensuring you feel supported throughout the process.
Cartiva Implant Cancer Link
No, the Cartiva implant doesn’t flat-out give you cancer – no big proof ties it straight to tumors yet. But its jelly material bugs your body a lot, starting a “hey, get out!” fight that makes big, hard lumps called silastic granulomas grow around the toe. These lumps balloon up, throb bad, and look just like tumors on X-rays or scans (kinda like sarcomas or lymphomas), scaring folks into extra pokes, cuts, or biopsies to prove it’s not real cancer – super stressful and pricey.
The company’s rules already yell “skip Cartiva if you’ve had cancer, bone tumors, hip slips, weak bones, steroids, transplants, or immune meds” – these mess with bone power and could spark wild growths or make the plug flop harder. Lawsuits say Stryker hid these lump risks (plus cysts and bone spikes), even with data showing ’em in busted implants, leading to months of cancer worry. If your toe got puffy, red-hot, or lumpy post-implant (and docs checked for tumors), write it down – it amps up your case for extra cash on top of pain claims. No full cancer link locked in, but these scares are pumping lawsuits for bigger wins. Direc2Attorney links you to pros spotting these ties – free review today!
If you’ve experienced health issues due to Cartiva implant, we are here to help you secure the compensation you deserve. Contact Us
Cartiva Implant Lawsuit Update 2025 – What’s Happening Right Now
Back in October 2024, the FDA yanked all Cartiva implants (made since 2016) after 144+ nightmare tales showed flops way higher than promised – docs had to trash extras, watch patients tight, and quit using it. That sparked a lawsuit flood: 200+ cases by December 2025 in spots like West Virginia, Pennsylvania, Maryland – no big group trial (MDL) bundled yet, but bets are on for 2026 to share clues faster. New ones keep dropping, like a September Pennsylvania suit yelling 64% early fails with bone/nerve smash and forced toe glues, plus November Maryland hits on joint wreck.
Test cases are sliding: Bryan Hughes’ fight (2019 plug bombed by 2023) jumped from October 28, 2025, to August 3, 2026, after both sides begged more prep time; Tammy May’s (flopped pre-yank) to August 17, 2026, with Judge Irene Berger pushing deal chats 30 days early. Sneaky quits (like Philippe Magloire’s May 2025 drop) smell like secret pays or “pause” deals to hold claim timers. No big settlement pool announced, but experts eye a monster group payout in 2026-2027, like Stryker’s past hip/knee fixes – $100K-$500K average per person, jumping for rough redo ops or lump panics. Mass tort tip: Jump in quick for top spot before rules set – time’s ticking on file limits. Direc2Attorney matches you free to fighters – call for your no-risk eval!
Yes – almost everyone with pain, swelling, or second surgery qualifies.
Over 200 strong cases filed nationwide and the number is growing fast every week.
No direct cancer, but it makes scary lumps that look like tumors and need biopsies.
Yes, but you only have 1–3 years from when you knew it failed – act fast.
No, 100% free unless you win – lawyers only get paid from your settlement.
95%+ of people never see a courtroom – it settles with a check in the mail.
Just your implant surgery date and proof of problems – we get the rest for you.
